Radient Pharmaceuticals Corporation fka RXPC

[lakeshore555]

DFRANK and goldseeker, thanks for the enlightenment.

I learned something about 23andMe. I seriously thought they were trying to sell ancestry ONLY.

I don't see how Gartner could sell a blood test for "various types of cancer" when 23andMe can't sell a spit test for "various types of everything including cancer."

However, as I have stated before, I don't think Gartner thinks GCDx will make a profit selling DR-70. He is close to DR-70 -- he knows how it has failed globally, he knows it doesn't have FDA clearance for his proposed use, and he knows that a positive result from a DR-70 screening test would be problematic for the patient and for the doctor. I think he just wants to run a startup company for a few years that pays a salary to him and a couple of his ex-Provista friends.

The trick is to find investors who think they will profit from investing in GCDx. Gartner has been unsuccessful in that respect. I don't think that should surprise anyone.